Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Pigment Cell Melanoma Res. 2015 Nov;28(6):661–672. doi: 10.1111/pcmr.12412

Table 3.

Studies evaluating the mutation status of BRAF in dysplastic nevi

Study Nevi included BRAF
mutations
NRAS
mutations
(Pollock et al., 2003) Dysplastic nevi 4/5(80%) --
(Papp et al., 2005) Dysplastic nevi 4/18(22%) --
(Uribe et al., 2006) Atypical nevi 13/21(61.9%) --
(Saroufim et al., 2014) Dysplastic nevi 63/125(55.8%) --